Format

Send to

Choose Destination
See comment in PubMed Commons below
Lancet. 1999 Apr 10;353(9160):1253-7.

Hepatocellular carcinoma.

Author information

1
Department of Internal Medicine, University of Nebraska Medical Center, Omaha 66198-2009, USA.

Abstract

Hepatocellular carcinoma (HCC) for most patients is a terminal complication of chronic inflammatory and fibrotic liver disease. With regrettably few exceptions, treatment is largely palliative, and long-term survival is rare. However, the major causes of HCC worldwide are known and preventable. Hepatitis B and C exist only in man; the viruses have no known non-human reservoirs. Transmission of the viruses can be interrupted by vaccination against hepatitis B virus infection and improvements in medical techniques for hepatitis C, for which no vaccine has yet been developed.

Comment in

PMID:
10217098
DOI:
10.1016/S0140-6736(98)09148-X
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center